VIALASE DESIGNING AN IMAGE GUIDED FEMTOSECOND LASER FOR GLAUCOMA TREATMENT

Presenting Author: Shawn O'neil
Country: United States
mailto:shawn.oneil@vialase.com

 

ECS13
VIALASE DESIGNING AN IMAGE GUIDED FEMTOSECOND LASER FOR GLAUCOMA TREATMENT

S. O’neil1,*

1ViaLase, Aliso Viejo, United States

ViaLase, Inc. is a globally-minded, venture capital-backed, clinical stage medical technology company located in Aliso Viejo, CA.  ViaLase is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment that enhances glaucoma patient care. With a leadership team that has vast experience developing, designing, manufacturing, and commercializing the first femtosecond lasers for ophthalmic surgery for refractive and cataract patients, ViaLase is now bringing that expertise and innovation to glaucoma patients. ViaLase believes in collaborating closely with health care providers, payers, societies, and patients to inform our product development and commercial activities with the goal of bringing this revolutionary treatment to glaucoma patients across the globe.